{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T05:35:51Z","timestamp":1674538551002},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,9,29]],"date-time":"2010-09-29T00:00:00Z","timestamp":1285718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s10689-010-9389-7","type":"journal-article","created":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T13:20:32Z","timestamp":1285680032000},"page":"65-71","source":"Crossref","is-referenced-by-count":5,"title":["A new mutation of BRCA2 gene in an Italian healthy woman with familial breast cancer history"],"prefix":"10.1007","volume":"10","author":[{"given":"Maurizio","family":"Pisan\u00f2","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Mezzolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Maddalena","family":"Galante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Alemanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Manca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Malvasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Tinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,29]]},"reference":[{"issue":"2","key":"9389_CR1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10555-010-9218-3","volume":"29","author":"A Tinelli","year":"2010","unstructured":"Tinelli A, Malvasi A, Leo G, Vergara D, Pisan\u00f2 M, Ciccarese M, Chiuri VE, Lorusso V (2010) Hereditary ovarian cancers: from BRCA mutations to clinical management a modern appraisal. Cancer Metastasis Rev 29(2):339\u2013350","journal-title":"Cancer Metastasis Rev"},{"key":"9389_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.2007.53","volume":"40","author":"MR Stratton","year":"2008","unstructured":"Stratton MR, Rahman N (2008) The emerging landscape of breast cancer susceptibility. Nat Genet 40:17\u201322","journal-title":"Nat Genet"},{"key":"9389_CR3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.2007.55-a","volume":"299","author":"CB Begg","year":"2008","unstructured":"Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L, Olsen JH, Lynch CF, Anton-Culver H, Capanu M, Liang X, Hummer AJ, Sima C, Bernstein JL (2008) Variation of breast cancer risk among BRCA1\/2 carriers. J Am Med Assoc 299:194\u2013201","journal-title":"J Am Med Assoc"},{"key":"9389_CR4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/90108","volume":"28","author":"X Xu","year":"2001","unstructured":"Xu X, Qiao W, Linke SP, Cao L, Li WM, Furth PA, Harris CC, Deng CX (2001) Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat Genet 28:266\u2013271","journal-title":"Nat Genet"},{"key":"9389_CR5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ng747","volume":"29","author":"J Jonkers","year":"2001","unstructured":"Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A (2001) Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29:418\u2013425","journal-title":"Nat Genet"},{"key":"9389_CR6","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1126\/science.297.5588.1837","volume":"297","author":"H Yang","year":"2002","unstructured":"Yang H, Jeffrey PD, Miller J, Kinnucan E, Sun Y, Thomav NH, Zheng N, Chen PL, Lee WH, Pavletich NP (2002) BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 297:1837\u20131848","journal-title":"Science"},{"key":"9389_CR7","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nature03404","volume":"434","author":"F Esashi","year":"2005","unstructured":"Esashi F, Christ N, Gannon J, Liu Y, Hunt T, Jasin M, West SC (2005) CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature 434:598\u2013604","journal-title":"Nature"},{"issue":"24","key":"9389_CR8","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1073\/pnas.0407266102","volume":"102","author":"VE Galkin","year":"2005","unstructured":"Galkin VE, Esashi F, Yu X, Yang S, West SC, Egelman EH (2005) BRCA2 BRC motifs bind RAD51-DNA filaments. Proc Natl Acad Sci 102(24):8537\u20138542","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"9389_CR9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1097-2765(01)00174-5","volume":"7","author":"ME Moynahan","year":"2001","unstructured":"Moynahan ME, Pierce AJ, Jasin M (2001) BRCA2 is required for homology-directed repair of chromosomal breaks. Mol Cell 7(2):263\u2013272","journal-title":"Mol Cell"},{"key":"9389_CR10","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0960-9822(99)80479-5","volume":"9","author":"A Tutt","year":"1999","unstructured":"Tutt A, Gabriel A, Bertwistle D, Connor F, Paterson H, Peacock J, Ross G, Ashworth A (1999) Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification. Curr Biol 9:1107\u20131110","journal-title":"Curr Biol"},{"issue":"5697","key":"9389_CR11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1102574","volume":"306","author":"MJ Daniels","year":"2004","unstructured":"Daniels MJ, Wang Y, Lee M, Venkitaraman AR (2004) Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science 306(5697):876\u2013879","journal-title":"Science"},{"issue":"1","key":"9389_CR12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-2143(99)90049-5","volume":"134","author":"K Golen Van","year":"1999","unstructured":"Van Golen K, Milliron K, Davies S, Merajver SD (1999) BRCA-associated cancer risk: molecular biology and clinical practice. J Lab Clin Med 134(1):11\u201318","journal-title":"J Lab Clin Med"},{"key":"9389_CR13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/humu.20319","volume":"27","author":"X Chen","year":"2006","unstructured":"Chen X, Truong TT, Weaver J, Bove BA, Cattie K, Armstrong BA, Daly MB, Godwin AK (2006) Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression. Hum Mutat 27:427\u2013435","journal-title":"Hum Mutat"},{"issue":"9","key":"9389_CR14","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1158\/0008-5472.CAN-07-1587","volume":"68","author":"DJ Farrugia","year":"2008","unstructured":"Farrugia DJ, Agarwal MK, Deffenbaugh AM, Pruss D, Frye C, Wenstrup RJ, Wadum L, Johnson K, Mentlick J, Tavtigian SV, Goldgar DE, Couch FJ (2008) Functional assays for classification of BRCA2 variants of uncertain significance. Cancer Res 68(9):3523\u20133531","journal-title":"Cancer Res"},{"issue":"Pt 4","key":"9389_CR15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1042\/BST0330715","volume":"33","author":"T Hay","year":"2005","unstructured":"Hay T, Clarke AR (2005) DNA damage hypersensitivity in cells lacking BRCA2: a review of in vitro and in vivo data. Biochem Soc Trans 33(Pt 4):715\u2013717","journal-title":"Biochem Soc Trans"},{"issue":"7182","key":"9389_CR16","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nature06548","volume":"451","author":"S Edwards","year":"2008","unstructured":"Edwards S, Brough R, Lord CJ, Natrajan R, Vatcheva R, Levine DA, Boyd J, Reis-Filho JS, Ashworth A (2008) Resistance to therapy caused by intragenic deletion in BRCA2. Nature 451(7182):1111\u20131115","journal-title":"Nature"},{"issue":"2","key":"9389_CR17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJMe0903044","volume":"361","author":"JD Iglehart","year":"2009","unstructured":"Iglehart JD, Silver DP (2009) Synthetic lethality\u2014a new direction in cancer-drug development. N Engl J Med 361(2):189\u2013191","journal-title":"N Engl J Med"},{"issue":"2","key":"9389_CR18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","volume":"361","author":"PC Fong","year":"2009","unstructured":"Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O\u2019Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JHM, de Bono JS (2009) Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. New Engl J Med 361(2):123\u2013134","journal-title":"New Engl J Med"},{"key":"9389_CR19","doi-asserted-by":"crossref","first-page":"13920","DOI":"10.1073\/pnas.96.24.13920","volume":"96","author":"BH Spain","year":"1999","unstructured":"Spain BH, Larson CJ, Shihabuddin LS, Gage FH, Verma IM (1999) Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations. Proc Natl Acad Sci USA 96:13920\u201313925","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"9389_CR20","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/jmg.2004.024133","volume":"42","author":"AC Antoniou","year":"2005","unstructured":"Antoniou AC, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2005) Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet 42(7):602\u2013603","journal-title":"J Med Genet"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-010-9389-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-010-9389-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-010-9389-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:46:04Z","timestamp":1559252764000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-010-9389-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,29]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["9389"],"URL":"https:\/\/doi.org\/10.1007\/s10689-010-9389-7","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,29]]}}}